RTTNews | Oct 6, 2021 11:16AM EDT

11:16 Wednesday, October 6, 2021 (RTTNews.com) - New Jersey-based healthcare company Rafael Holdings, Inc. (RFL) is up 6% on the Wednesday market. The company has reported the hiring of Mary Margaret (Mimi) Huizinga as the Chief Development and Medical Officer of the company. She is going to be an integral figure in the company's cancer metabolism therapy development. She will assume office from October 18. Dr. Huizinga, an MD and MPH from Vanderbilt University and is a fellow of the American College of Physicians, was the head of US Oncology Medical at Novartis and prior to that, she was the Chief Health Information Officer at Premier, Inc and also led the Applied Sciences division f the company. "It is exciting to be joining the Rafael Holdings executive management team later this month. I look forward to collaborating with the Rafael Pharmaceuticals organization in the development of cancer metabolism therapeutic programs as it approaches a critical inflection point with the data readout for its Phase 3 clinical trial for CPI-613 in metastatic pancreatic cancer in the fourth quarter of this year," said Dr. Huizinga. The stock of Raphael is currently trading at $33.51, up $1.35 or 4.20% from the previous close at $32.16. The shares opened at $35.47 in the morning and in the 52-week period, the shares have ranged between $15.08 and $66.44 per share.

Read the original article on RTTNews ( https://www.rttnews.com/3230913/rafael-up-8-appoints-mimi-huizinga-as-new-cdmo.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved